Trust Stamp (NASDAQ:IDAI, EURONEXT:AIID) Inc said it has named Professor Reuben Farrugia as Malta Research Director amid the company's ongoing investment in research and development alongside multiple patent filings in early 2022.
As an internationally recognized authority in biometrics with nearly two decades of experience in image processing and computer vision and over 70 international peer-reviewed publications, the company said Farrugia brings deep expertise to the Trust Stamp (NASDAQ:IDAI, EURONEXT:AIID) team.
He’s an associate professor at the University of Malta, National Contact for the European Association of Biometrics (EAB), and an IEEE senior member, having previously served as General Chair to the IEEE International Workshop on Biometrics and Forensics.
READ: Trust Stamp receives funding commitment from Malta Enterprise to develop next-generation medical-record QR Code
"Trust Stamp (NASDAQ:IDAI, EURONEXT:AIID) has established a strong research-oriented science team with experts in artificial intelligence, cryptography, and biometrics, whose global backgrounds and diverse experience have driven innovation as the basis for the Company's rapid success over the last six years. Reuben is a valuable addition to our team with exceptional insight and a highly developed skillset in the field of biometrics,” said Trust Stamp Chief Technology Officer Scott Francis in a statement.
“Continuing momentum from our record success in 2021 and Nasdaq listing in January of this year, Trust Stamp looks forward to working with Reuben to further develop, patent, and deliver new technologies that accelerate secure financial and societal inclusion while growing long-term recurring revenue."
Trust Stamp said its continued push to innovate transformative privacy-first solutions follows multiple patents applications filed at the beginning of 2022 and recently announced financial support from Malta Enterprise for their next-generation Medical QR Code solution that layers data privacy, protection, and portability to complement current and future digital health certificate programs using the company's advanced tokenization technology to enable user-controlled access to medical data both on and offline.
Protected by Trust Stamp's comprehensive presentation attack detection capabilities, the innovation works across identity modalities including the company's own expanding range of biometric capture and analysis tools for facial, palm, and fingerprint biometrics, which are optimized for accurate authentication without sharing any biometric data, using just a mobile phone.
With continued growth in European operations, Trust Stamp recently announced the appointment of Josh Allen as CEO of its Malta and Rwanda-based subsidiaries. Celebrating this ongoing progress, Malta Minister for Energy, Enterprise and Sustainable Development Dr. Miriam Dalli visited Trust Stamp's European R&D hub earlier this month.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham